KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,177,600 | -17.3% | 2,980,000 | -4.0% | 0.42% | -4.9% |
| Q2 2023 | $32,850,900 | -13.5% | 3,105,000 | 0.0% | 0.45% | -20.8% |
| Q1 2023 | $37,974,150 | -1.5% | 3,105,000 | 0.0% | 0.56% | -2.3% |
| Q4 2022 | $38,533,050 | -20.0% | 3,105,000 | -11.9% | 0.58% | -35.3% |
| Q3 2022 | $48,152,000 | -45.3% | 3,525,000 | -26.6% | 0.89% | -48.8% |
| Q2 2022 | $87,984,000 | +14.0% | 4,800,000 | 0.0% | 1.74% | +23.4% |
| Q1 2022 | $77,184,000 | +37.8% | 4,800,000 | +20.0% | 1.41% | +47.8% |
| Q4 2021 | $56,000,000 | -25.3% | 4,000,000 | 0.0% | 0.95% | -19.0% |
| Q3 2021 | $74,920,000 | -13.2% | 4,000,000 | -3.4% | 1.18% | -21.6% |
| Q2 2021 | $86,319,000 | -23.7% | 4,140,000 | +3.5% | 1.50% | -23.1% |
| Q1 2021 | $113,080,000 | -13.4% | 4,000,000 | 0.0% | 1.95% | -13.2% |
| Q4 2020 | $130,640,000 | +75.1% | 4,000,000 | +64.3% | 2.25% | +112.3% |
| Q3 2020 | $74,608,000 | +335.9% | 2,435,000 | +131.9% | 1.06% | +213.6% |
| Q2 2020 | $17,115,000 | – | 1,050,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |